COLUMBIA, Md., Sept. 27 /PRNewswire-FirstCall/ -- Martek Biosciences, a DHA omega-3 market leader, announced today that NutraBella has introduced under the Bellybar(TM) brand, new and improved flavors featuring Martek's life'sDHA(TM), Martek's patented, vegetarian form of DHA omega-3. Bellybar(TM), an all-natural line of snack bars designed to meet the nutritional needs of women before, during and after pregnancy, now includes 50 mg per bar of life'sDHA(TM), a fatty acid important for brain, eye, and nervous system development in infants that may also play a role in maternal well-being. Already in the Burstin' Chocolate variety, NutraBella has now added life'sDHA(TM) to the entire line of Bellybar(TM) products, providing women with additional flavors packed with nutrients that will not conflict with their prenatal supplements. All varieties are currently available at select Whole Foods Markets, Wild Oats Markets, Babies 'R Us, Mimi Maternity, Motherhood Maternity, Wegmans, Pharmaca, HEB and other select retailers around the United States.
"In developing Bellybar(TM), our goal has been to constantly deliver the best possible products for women pre-conception, during pregnancy and while nursing. We are so pleased to be launching additional products that provide life'sDHA(TM), along with other key prenatal vitamins and minerals, while maintaining the exceptional taste that women expect from Bellybar," said Meredith Lincoln, Co-Founder of NutraBella.
"We are pleased to be working with NutraBella on these additional varieties of their Bellybar(TM) product in order to provide women with more opportunities to ensure their diets contain adequate amounts of DHA omega-3 for both their health and the development of their babies," said Steve Dubin, Martek's CEO.
DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews have noted the importance of DHA omega-3 in proper brain and eye function, and there are studies currently underway to investigate its role in decreasing the prevalence of certain neurological disorders. Yet despite its importance, Americans have among the lowest dietary intakes of DHA omega-3 in the world.
Martek's life'sDHA(TM) is unique in the market because it is derived from a sustainable and vegetarian source. Made from microalgae under tightly controlled manufacturing conditions, life'sDHA(TM) is free of oceanic contaminants that may be present in certain fish or fish oils. Microalgae are the only vegetarian source of DHA omega-3, the key omega-3 for brain and eye development and function.
NutraBella, founded in 2004, is an all-natural food products company that promotes good nutrition and a better way to get the critical nutrients needed before, during and after pregnancy. For more information, visit http://www.BellyProducts.com.
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.
Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.
Contact: Philip Fass
|SOURCE Martek Biosciences Corporation|
Copyright©2007 PR Newswire.
All rights reserved